Lunai Bioworks Inc. Comprehensive Income
Lunai Bioworks Inc. (LNAI) reported Comprehensive Income of -$2.59 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-05-15.
Financial Statements › Income Statement
us-gaap:ComprehensiveIncomeNetOfTax · last filed 2026-05-15
- Lunai Bioworks Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2026-03-31 was -$2.59M, a 153.78% decline year-over-year.
- Lunai Bioworks Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-12-31 was -$1.81M.
- Lunai Bioworks Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-09-30 was -$8.12M.
- Lunai Bioworks Inc. comprehensive income (loss), net of tax, attributable to parent for the quarter ending 2025-06-30 was -$116.69M.
- Lunai Bioworks Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2025 was -$167.02M.
- Lunai Bioworks Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2024 was -$88.57M.
- Lunai Bioworks Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2023 was -$39.68M.
- Lunai Bioworks Inc. comprehensive income (loss), net of tax, attributable to parent for fiscal 2022 was -$113.45M.
| Period end | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 3 month as first filed | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 6 month as first filed | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 9 month as first filed | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month | Comprehensive Income (Loss), Net of Tax, Attributable to Parent 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | -$2.59M 10-Q · filed 2026-05-15 | -$4.40M derived: sum of 2 quarters · filed 2026-05-15 | -$12.52M 10-Q · filed 2026-05-15 | -$129.22M derived: sum of 4 quarters · filed 2026-05-15 | ||||
| 2025-12-31 | -$1.81M 10-Q · filed 2026-02-17 | -$9.93M 10-Q · filed 2026-02-17 | -$126.63M derived: sum of 3 quarters · filed 2026-02-17 | -$121.81M derived: sum of 4 quarters · filed 2026-05-15 | ||||
| 2025-09-30 | -$8.12M 10-Q · filed 2025-11-14 | -$124.82M derived: sum of 2 quarters · filed 2025-11-14 | -$120.00M derived: sum of 3 quarters · filed 2026-05-15 | -$137.40M derived: sum of 4 quarters · filed 2026-05-15 | ||||
| 2025-06-30 | -$116.69M derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-29 | -$111.88M derived: sum of 2 quarters · filed 2026-05-15 | -$129.28M derived: sum of 3 quarters · filed 2026-05-15 | -$167.02M 10-K · filed 2025-09-29 | ||||
| 2025-03-31 | $4.81M 10-Q · filed 2026-05-15 | -$12.58M derived: sum of 2 quarters · filed 2026-05-15 | -$50.33M 10-Q · filed 2026-05-15 | -$67.27M derived: sum of 4 quarters · filed 2026-05-15 | ||||
| 2024-12-31 | -$17.40M 10-Q · filed 2026-02-17 | -$55.14M 10-Q · filed 2026-02-17 | -$72.08M derived: sum of 3 quarters · filed 2026-02-17 | -$130.01M derived: sum of 4 quarters · filed 2026-02-17 | ||||
| 2024-09-30 | -$37.74M 10-Q · filed 2025-11-14 | -$54.68M derived: sum of 2 quarters · filed 2025-11-14 | -$112.61M derived: sum of 3 quarters · filed 2025-11-14 | -$117.10M derived: sum of 4 quarters · filed 2025-11-14 | ||||
| 2024-06-30 | -$16.94M derived: 10-K 12 month − 10-Q 9 month · filed 2025-09-29 | -$74.87M derived: sum of 2 quarters · filed 2025-09-29 | -$79.36M derived: sum of 3 quarters · filed 2025-09-29 | -$88.57M 10-K · filed 2025-09-29 | -$80.79M 10-K · filed 2024-10-10 | |||
| 2024-03-31 | -$57.93M 10-Q · filed 2025-05-15 | -$15.96M 10-Q · filed 2024-05-15 | -$62.42M derived: sum of 2 quarters · filed 2025-05-15 | -$71.63M 10-Q · filed 2025-05-15 | -$29.66M 10-Q · filed 2024-05-15 | -$94.83M derived: sum of 4 quarters · filed 2025-05-15 | ||
| 2023-12-31 | -$4.49M 10-Q · filed 2025-02-19 | -$13.70M 10-Q · filed 2025-02-19 | -$36.90M derived: sum of 3 quarters · filed 2025-02-19 | -$41.23M derived: sum of 4 quarters · filed 2025-02-19 | ||||
| 2023-09-30 | -$9.21M 10-Q/A · filed 2025-02-19 | -$32.41M derived: sum of 2 quarters · filed 2025-02-19 | -$36.74M derived: sum of 3 quarters · filed 2025-02-19 | -$41.19M derived: sum of 4 quarters · filed 2025-02-19 | ||||
| 2023-06-30 | -$23.20M derived: 10-K/A 12 month − 10-Q/A 9 month · filed 2025-02-19 | -$27.53M derived: sum of 2 quarters · filed 2025-02-19 | -$31.98M derived: sum of 3 quarters · filed 2025-02-19 | -$39.68M 10-K/A · filed 2025-02-19 | ||||
| 2023-03-31 | -$4.33M 10-Q/A · filed 2025-02-19 | -$8.78M derived: sum of 2 quarters · filed 2025-02-19 | -$16.49M 10-Q/A · filed 2025-02-19 | -$106.73M derived: sum of 4 quarters · filed 2025-02-19 | ||||
| 2022-12-31 | -$4.45M 10-Q · filed 2024-02-14 | -$12.16M 10-Q · filed 2024-02-14 | -$102.40M derived: sum of 3 quarters · filed 2024-02-14 | -$108.61M derived: sum of 4 quarters · filed 2024-02-14 | ||||
| 2022-09-30 | -$7.71M 10-Q · filed 2023-11-14 | -$97.95M derived: sum of 2 quarters · filed 2023-11-14 | -$104.16M derived: sum of 3 quarters · filed 2023-11-14 | -$110.74M derived: sum of 4 quarters · filed 2023-11-14 | ||||
| 2022-06-30 | -$90.25M derived: 10-K 12 month − 10-Q 9 month · filed 2023-10-02 | -$96.45M derived: sum of 2 quarters · filed 2023-10-02 | -$103.04M derived: sum of 3 quarters · filed 2023-10-02 | -$113.45M 10-K · filed 2023-10-02 | ||||
| 2022-03-31 | -$6.20M 10-Q · filed 2023-05-12 | -$12.79M derived: sum of 2 quarters · filed 2023-05-12 | -$23.21M 10-Q · filed 2023-05-12 | -$40.57M derived: sum of 4 quarters · filed 2023-05-12 | ||||
| 2021-12-31 | -$6.59M 10-Q · filed 2023-03-09 | -$17.00M 10-Q · filed 2023-03-09 | -$34.36M derived: sum of 3 quarters · filed 2023-03-09 | -$38.40M derived: sum of 4 quarters · filed 2023-03-09 | ||||
| 2021-09-30 | -$10.42M 10-Q · filed 2023-03-07 | -$27.78M derived: sum of 2 quarters · filed 2023-03-07 | -$31.82M derived: sum of 3 quarters · filed 2023-03-07 | -$34.74M derived: sum of 4 quarters · filed 2023-03-07 | ||||
| 2021-06-30 | -$17.36M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | -$21.40M derived: sum of 2 quarters · filed 2023-02-27 | -$24.32M derived: sum of 3 quarters · filed 2023-02-27 | -$26.69M 10-K · filed 2023-02-27 | ||||
| 2021-03-31 | -$4.04M 10-Q · filed 2022-05-13 | -$6.96M derived: sum of 2 quarters · filed 2022-05-13 | -$9.33M 10-Q · filed 2022-05-13 | -$13.46M derived: sum of 4 quarters · filed 2022-05-13 | ||||
| 2020-12-31 | -$2.92M 10-Q · filed 2022-02-14 | -$5.29M 10-Q · filed 2022-02-14 | -$9.42M derived: sum of 3 quarters · filed 2022-02-14 | -$10.94M derived: sum of 4 quarters · filed 2022-02-14 | ||||
| 2020-09-30 | -$2.37M 10-Q · filed 2021-11-15 | -$6.49M derived: sum of 2 quarters · filed 2021-11-15 | -$8.02M derived: sum of 3 quarters · filed 2021-11-15 | -$9.61M derived: sum of 4 quarters · filed 2021-11-15 | ||||
| 2020-06-30 | -$4.12M derived: 10-K 12 month − 10-Q 9 month · filed 2021-09-24 | -$5.65M derived: sum of 2 quarters · filed 2021-09-24 | -$7.24M derived: sum of 3 quarters · filed 2021-09-24 | -$11.60M 10-K · filed 2021-09-24 | ||||
| 2020-03-31 | -$1.52M 10-Q · filed 2021-05-17 | -$3.11M derived: sum of 2 quarters · filed 2021-05-17 | -$7.48M 10-Q · filed 2021-05-17 | -$6.40M derived: sum of 4 quarters · filed 2021-05-17 | ||||
| 2019-12-31 | -$1.59M 10-Q · filed 2021-02-16 | -$5.95M 10-Q · filed 2021-02-16 | -$4.88M derived: sum of 3 quarters · filed 2021-02-16 | -$7.75M derived: sum of 4 quarters · filed 2021-02-16 | ||||
| 2019-09-30 | -$4.36M 10-Q · filed 2020-11-12 | -$3.29M derived: sum of 2 quarters · filed 2020-11-12 | -$6.16M derived: sum of 3 quarters · filed 2020-11-12 | -$22.04M derived: sum of 4 quarters · filed 2020-11-12 | ||||
| 2019-06-30 | $1.07M derived: 10-K 12 month − 10-Q 9 month · filed 2020-09-23 | -$1.80M derived: sum of 2 quarters · filed 2020-09-23 | -$17.68M derived: sum of 3 quarters · filed 2020-09-23 | -$18.12M 10-K · filed 2020-09-23 | ||||
| 2019-03-31 | -$2.87M 10-Q · filed 2020-05-11 | -$4.57M 10-Q · filed 2019-05-16 | -$18.75M derived: sum of 2 quarters · filed 2020-05-11 | -$19.19M 10-Q · filed 2020-05-11 | $35.01M 10-Q · filed 2019-05-16 | -$20.77M derived: sum of 4 quarters · filed 2020-05-11 | ||
| 2018-12-31 | -$15.88M 10-Q · filed 2020-02-10 | -$17.77M 10-Q · filed 2019-02-13 | -$16.32M 10-Q · filed 2020-02-10 | -$20.16M 10-Q · filed 2019-02-13 | -$17.90M derived: sum of 3 quarters · filed 2020-02-10 | -$18.14M derived: sum of 4 quarters · filed 2020-02-10 | ||
| 2018-09-30 | -$441.60K 10-Q · filed 2019-11-13 | -$2.39M 10-Q · filed 2018-11-14 | -$2.02M derived: sum of 2 quarters · filed 2019-11-13 | -$2.25M derived: sum of 3 quarters · filed 2019-11-13 | -$2.38M derived: sum of 4 quarters · filed 2019-11-13 | |||
| 2018-06-30 | -$1.58M derived: 10-K 12 month − 10-Q 9 month · filed 2019-09-30 | -$1.81M derived: sum of 2 quarters · filed 2019-09-30 | -$1.94M derived: sum of 3 quarters · filed 2019-09-30 | -$6.46M 10-K · filed 2019-09-30 | -$9.30M 10-K · filed 2018-10-01 | |||
| 2018-03-31 | -$235.96K 10-Q · filed 2019-05-16 | -$3.20M 10-Q · filed 2018-05-15 | -$365.95K derived: sum of 2 quarters · filed 2019-05-16 | -$4.88M 10-Q · filed 2019-05-16 | -$1.29M derived: sum of 4 quarters · filed 2019-05-16 | |||
| 2017-12-31 | -$129.99K 10-Q · filed 2019-05-16 | -$1.21M 10-Q · filed 2018-02-09 | -$1.69M 10-Q · filed 2019-02-13 | -$1.05M derived: sum of 3 quarters · filed 2019-05-16 | -$1.41M derived: sum of 4 quarters · filed 2019-05-16 | |||
| 2017-09-30 | -$255.18K 10-Q · filed 2019-05-16 | -$480.96K 10-Q · filed 2017-11-20 | -$922.50K derived: sum of 2 quarters · filed 2019-05-16 | -$1.28M derived: sum of 3 quarters · filed 2019-05-16 | -$1.79M derived: sum of 4 quarters · filed 2019-05-16 | |||
| 2017-06-30 | -$667.32K derived: 10-K 12 month − 10-Q 9 month · filed 2018-10-01 | -$1.02M derived: sum of 2 quarters · filed 2018-10-01 | -$1.54M derived: sum of 3 quarters · filed 2018-10-01 | -$2.35M 10-K · filed 2018-10-01 | -$2.60M 10-K · filed 2017-09-29 | |||
| 2017-03-31 | -$353.75K 10-Q · filed 2018-05-15 | -$868.14K derived: sum of 2 quarters · filed 2018-05-15 | -$1.69M 10-Q · filed 2017-05-15 | -$2.26M derived: sum of 4 quarters · filed 2018-05-15 | ||||
| 2016-12-31 | -$514.39K 10-Q · filed 2018-02-09 | -$1.33M 10-Q · filed 2018-02-09 | -$1.91M derived: sum of 3 quarters · filed 2018-02-09 | -$2.41M derived: sum of 4 quarters · filed 2018-02-09 | ||||
| 2016-09-30 | -$818.77K 10-Q · filed 2017-11-20 | -$1.39M derived: sum of 2 quarters · filed 2017-11-20 | -$1.90M derived: sum of 3 quarters · filed 2017-11-20 | -$2.17M derived: sum of 4 quarters · filed 2017-11-20 | ||||
| 2016-06-30 | -$574.01K derived: 10-K 12 month − 10-Q 9 month · filed 2017-11-20 | -$1.08M derived: sum of 2 quarters · filed 2017-11-20 | -$1.35M derived: sum of 3 quarters · filed 2017-11-20 | -$1.71M 10-K · filed 2017-11-20 | ||||
| 2016-03-31 | -$505.16K 10-Q · filed 2017-05-15 | -$780.71K derived: sum of 2 quarters · filed 2017-05-15 | -$1.14M 10-Q · filed 2017-05-15 | -$2.74M derived: sum of 4 quarters · filed 2017-05-15 | ||||
| 2015-12-31 | -$275.54K 10-Q · filed 2017-02-14 | -$635.66K 10-Q · filed 2017-02-14 | -$2.23M derived: sum of 3 quarters · filed 2017-02-14 | -$3.04M derived: sum of 4 quarters · filed 2017-02-14 | ||||
| 2015-09-30 | -$360.12K 10-Q · filed 2016-11-14 | -$1.95M derived: sum of 2 quarters · filed 2016-11-14 | -$2.77M derived: sum of 3 quarters · filed 2016-11-14 | -$3.64M derived: sum of 4 quarters · filed 2016-11-14 | ||||
| 2015-06-30 | -$1.59M derived: 10-K 6 month − 10-Q 3 month · filed 2016-09-28 | -$2.41M 10-K · filed 2016-09-28 | -$3.28M derived: sum of 3 quarters · filed 2016-09-28 | -$3.60M derived: sum of 4 quarters · filed 2016-09-28 | ||||
| 2015-03-31 | -$810.77K 10-Q · filed 2016-05-13 | -$1.69M derived: sum of 2 quarters · filed 2016-05-13 | -$2.01M 10-Q · filed 2016-05-13 | -$2.45M derived: sum of 4 quarters · filed 2016-05-13 | ||||
| 2014-12-31 | -$877.39K 10-Q · filed 2016-02-12 | -$1.20M 10-Q · filed 2016-02-12 | -$1.64M derived: sum of 3 quarters · filed 2016-02-12 | -$2.06M 10-K · filed 2016-09-28 | ||||
| 2014-09-30 | -$319.62K 10-Q · filed 2015-11-13 | -$757.64K derived: sum of 2 quarters · filed 2015-11-13 | -$1.19M derived: sum of 3 quarters · filed 2015-11-13 | |||||
| 2014-06-30 | -$438.02K derived: 10-KT 6 month − 10-Q 3 month · filed 2015-09-28 | -$867.43K 10-KT · filed 2015-09-28 | ||||||
| 2014-03-31 | -$429.41K 10-Q · filed 2015-05-13 | |||||||
| 2013-12-31 | -$2.37M 10-KT · filed 2015-09-28 | |||||||
| 2013-03-31 | -$538.12K 10-Q · filed 2014-05-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |